Skip to content

Research on the Effect and Mechanism of Transcutaneous Auricular Vagus Nerve Stimulation in the Treatment of Parkinson's Disease

Based on the microbiota–gut–brain axis exploring the role and mechanism of transcutaneous auricular vagus nerve stimulation in the treatment of Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001470
Enrollment
Unknown
Registered
2025-07-21
Start date
2021-05-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Control Group:Auricular Non-Vagus Nerve Stimulation Group
Experimental Group:Transcutaneous Auricular Vagus Nerve Stimulation Group

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosis of Parkinson's disease (PD) meets the "2015 MDS Diagnostic Criteria for Parkinson's Disease" without head tremor. 2.Hoehn and Yahr stage is between I and III. 3. Age between 35 and 80 years. 4.The patient voluntarily agrees to participate in this study and has signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients diagnosed with secondary parkinsonism or Parkinson-plus syndromes. 2.Patients with severe diseases of the heart liver kidneys or hematopoietic system or with malignant tumors; those with other neurological disorders psychiatric conditions a history of traumatic brain injury or previous brain surgery. 3.Patients who are unable to undergo fMRI examination for any reason.

Design outcomes

Primary

MeasureTime frame
Movement Disothe Unified Parkinsons Disease Rating Scale;

Secondary

MeasureTime frame
Patient Assessment of Constipation – Symptoms;fMRI;Patient Assessment of Constipation – Quality of Life;Hamilton Depression Rating Scale;Scales for Outcomes in Parkinson's Disease – Autonomic;Hamilton Anxiety Rating Scale;

Countries

China

Contacts

Public ContactZhe Li

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)

zhel@gzucm.edu.cn18064108739

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026